ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 124 filers reported holding ANIKA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,028,599 | -47.8% | 55,212 | -27.2% | 0.00% | -33.3% |
Q2 2023 | $1,970,089 | +38.4% | 75,831 | +53.0% | 0.00% | +50.0% |
Q1 2023 | $1,423,449 | -1.2% | 49,563 | +1.9% | 0.00% | 0.0% |
Q4 2022 | $1,440,247 | -19.0% | 48,657 | -34.9% | 0.00% | -33.3% |
Q3 2022 | $1,778,000 | +8.3% | 74,737 | +1.6% | 0.00% | 0.0% |
Q2 2022 | $1,641,000 | +266.3% | 73,539 | +311.8% | 0.00% | +200.0% |
Q1 2022 | $448,000 | -17.8% | 17,860 | +17.4% | 0.00% | 0.0% |
Q4 2021 | $545,000 | – | 15,216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |